Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Inactive hair follicle stem cells help prevent skin cancer.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Using finasteride with TIP extends time off period for prostate cancer patients.

Stem cells and their surrounding environment in hair follicles work closely together, affecting hair growth and having implications for cancer and tissue regeneration.

Men with testicular cancer were less likely to experience baldness and severe acne.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

A mouse gene mutation increases the risk of skin cancer.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Germany recognizes skin cancer from UV exposure as an occupational disease, emphasizing prevention and care for affected workers.